COVID-19 and the Coronavirus Pandemic

UCS experts are closely tracking the ongoing outbreak and monitoring attempts by the Trump administration to sideline scientists and public health experts. Photo from the Pennsylvania Department of Health’s Bureau of Laboratories.


PA Governor's office/Flickr

The Quandary of COVID-19 Vaccine Trials for Black Americans Who (Rightfully) Distrust Medical Researchers

, Senior Climate Justice and Health Scientist

Well, here we are. The place where no one wanted to be. COVID-19 deaths in the U.S. have surpassed 200,000 Americans. Black Americans continue to experience the highest COVID-19 mortality rates nationwide, are almost five times more likely than White Americans to be hospitalized with COVID-19 and twice as likely to die from the disease. Despite those facts, Black people are not participating in the COVID-19 vaccine trials in large numbers. Read more >

PA Governor's office/Flickr
Bookmark and Share

US Air Force

Thank Science for Vaccines – Not Funders, Industries, or Politicians

, Research scientist

Science deserves all credit for the development of vaccines that will slow the spread of the novel coronavirus. While acknowledgement should certainly be given to those who have provided resources for the research, ultimately these individuals or organizations could not develop a vaccine without science. And those that have decided to selectively embrace science behind the development of a vaccine, while sidelining the science on nearly all other issues for political reasons, certainly do not deserve credit. Read more >

Bookmark and Share

Phil Roeder/Flickr

Political Officials Undermine CDC Scientists’ COVID-19 Studies

, Research Analyst

In a scary and dramatic shift away from normal, the entire process for publishing CDC reports on COVID-19 has been upended by political appointees at the Department of Health and Human Services (HHS) for reasons that appear to be entirely political, Politico reported late last week.

Read more >

Phil Roeder/Flickr
Bookmark and Share

Who Gets the First COVID-19 Vaccines? The Answer is a Complex Tangle of Science and Ethics

In a perfect world, a newly-approved COVID-19 vaccine would be immediately available to everyone, everywhere—a tantalizing vision, but constraints in manufacturing and public health infrastructure make this vision nearly impossible to achieve. The US expects to have enough doses to cover 10-15 million people soon after a vaccine is approved. This sounds like a hefty number, but it’s only 4-6 percent of the US population. So, who should get the first vaccines? Read more >

Bookmark and Share

Christopher Michel

The Evidence is Clear: The US Public Wants Science-Based Policies for COVID-19

You would think that after 190,000 COVID-19 deaths, the Trump administration might finally develop a national strategy to control spread of the coronavirus. No. Instead it foists on us a new member of the coronavirus task force with no expertise in infectious disease or epidemiology. Read more >

Bookmark and Share